keyword
https://read.qxmd.com/read/38644693/chronic-neutrophilic-leukemia-and-atypical-chronic-myeloid-leukemia-2024-update-on-diagnosis-genetics-risk-stratification-and-management
#1
REVIEW
Natasha Szuber, Attilio Orazi, Ayalew Tefferi
Chronic neutrophilic leukemia (CNL) is a rare BCR::ABL1-negative myeloproliferative neoplasm (MPN) defined by persistent mature neutrophilic leukocytosis and bone marrow granulocyte hyperplasia. Atypical chronic myeloid leukemia (aCML) (myelodysplastic "[MDS]/MPN with neutrophilia" per World Health Organization [WHO]) is a MDS/MPN overlap disorder featuring dysplastic neutrophilia and circulating myeloid precursors. Both manifest with frequent hepatosplenomegaly and less commonly, bleeding, with high rates of leukemic transformation and death...
April 21, 2024: American Journal of Hematology
https://read.qxmd.com/read/38642470/analysis-of-csf3r-mutations-in-atypical-chronic-myeloid-leukemia-and-other-myeloid-malignancies
#2
JOURNAL ARTICLE
Seon Young Kim, Ik-Chan Song, Jimyung Kim, Gye Cheol Kwon
We report a series of patients with CSF3R-mutant (CSF3Rmut ) atypical chronic myeloid leukemia (aCML), chronic neutrophilic leukemia (CNL) or other hematologic malignancies. We included 25 patients: 5 aCML and 4 CNL CSF3Rmut patients; 1 aCML, 2 CNL, and 2 myelodysplastic/myeloproliferative neoplasm, not otherwise specified patients without CSF3R mutation; and 11 CSF3Rmut patients with other diseases [8 acute myeloid leukemia (AML), 1 chronic myelomonocytic leukemia (CMML), 1 myelodysplastic syndrome (MDS), and 1 acute lymphoblastic leukemia (ALL)]...
April 18, 2024: Annals of Diagnostic Pathology
https://read.qxmd.com/read/38633119/graft-versus-host-disease-after-autologous-stem-cell-transplantation-in-a-recipient-who-underwent-allogeneic-stem-cell-transplantation-20-years-earlier
#3
JOURNAL ARTICLE
Osamu Imataki, Shunsuke Yoshida, Tomoya Ishida, Haruyuki Fujita, Makiko Uemura
A literature review does not provide information about the safety of autologous hematopoietic stem cell transplantation (HSCT) in a recipient who has previously received allogeneic HSCT. We treated a 69-year-old woman with diffuse large B cell lymphoma. The patient received autologous stem cell transplantation (ASCT) in the second complete remission of malignant lymphoma. The patient had undergone allogeneic hematopoietic SCT (allo-HSCT) for chronic myeloid leukemia 20 years ago. Chronic myeloid leukemia had been in complete remission for the previous 20 years...
April 2024: EJHaem
https://read.qxmd.com/read/38622430/presumed-pseudo-pelger-hu%C3%A3-t-anomaly-and-basophilia-secondary-to-chronic-lymphocytic-leukemia-in-a-dog
#4
Javier Martínez-Caro, Beatriz Agulla, Clàudia Viñeta, Xavier Roura, Montse Mesalles, Josep Pastor
A 10-year-old neutered male Maltese dog was presented for an investigation of lymphocytosis. The dog was up-to-date on vaccinations and deworming. Physical examination did not reveal any significant abnormalities. A complete blood cell count (CBC) showed mild leukocytosis with moderate lymphocytosis, basophilia, and moderate neutropenia, but no significant left shift or toxic change. Serum biochemistry and urinalysis were unremarkable. All performed tests for infectious agents common in this geographical region were negative...
April 15, 2024: Veterinary Clinical Pathology
https://read.qxmd.com/read/38612827/slam-family-receptors-in-b-cell-chronic-lymphoproliferative-disorders
#5
REVIEW
Dominik Kľoc, Slavomír Kurhajec, Mykhailo Huniadi, Ján Sýkora, Tomáš Guman, Marek Šarišský
The signaling lymphocytic activation molecule (SLAM) receptor family (SLAMF) consists of nine glycoproteins that belong to the CD2 superfamily of immunoglobulin (Ig) domain-containing molecules. SLAMF receptors modulate the differentiation and activation of a wide range of immune cells. Individual SLAMF receptors are expressed on the surface of hematopoietic stem cells, hematopoietic progenitor cells, B cells, T cells, NK cells, NKT cells, monocytes, macrophages, dendritic cells, neutrophils, and platelets...
April 4, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38570827/b-1-derived-anti-thy-1-b-cells-in-old-aged-mice-develop-lymphoma-leukemia-with-high-expression-of-cd11b-and-hamp2-that-different-from-tcl1-transgenic-mice
#6
JOURNAL ARTICLE
Kyoko Hayakawa, Yan Zhou, Susan A Shinton
Human old aged unmutated chronic lymphocytic leukemia U-CLL are the TCL1+ ZAP70+ CD5+ B cells. Since CD5 makes the BCR signaling tolerance, ZAP70 increased in U-CLL not only TCL1+ alone. In mice, TCL1 (TCL1A) is the negative from neonate to old aged, as TC- . VH 8-12/Vk 21-5 is the anti-thymocyte/Thy-1 autoreactive ATA B cell. When ATA μκTg generation in mice, ATA B cells are the neonate generated CD5+ B cells in B-1, and in the middle age, CD5+ can be down or continuously CD5+ , then, old aged CLL/lymphoma generation with increased CD11b in TC- ZAP70- CD5- or TC- ZAP70+ CD5+ ...
April 3, 2024: Immunity & Ageing: I & A
https://read.qxmd.com/read/38568024/white-blood-cell-count-neutrophil-to-lymphocyte-ratio-and-incident-cancer-in-the-uk-biobank
#7
JOURNAL ARTICLE
Minkyo Song, Barry I Graubard, Erikka Loftfield, Charles S Rabkin, Eric A Engels
BACKGROUND: The peripheral white blood cell (WBC) and neutrophil-to-lymphocyte ratio (NLR) reflect levels of inflammation and adaptive immunity. They are associated with cancer prognosis, but their associations with cancer incidence are not established. METHODS: We evaluated 443,540 cancer-free adults in the UK Biobank with data on total WBC and its subsets, follow-up starting one year after baseline. Cox regression was used to estimate hazard ratios (HRs) per quartile of WBC or NLR for incidence of 73 cancer types...
April 3, 2024: Cancer Epidemiology, Biomarkers & Prevention
https://read.qxmd.com/read/38531054/enhanced-mapk-signaling-induced-by-csf3rmutants-confers-dependence-to-dusp1-for-leukemic-transformation
#8
JOURNAL ARTICLE
Meenu Kesarwani, Zachary Kincaid, Mohammad Azhar, Mohammad Azam
Elevated MAPK and the JAK-STAT signaling play pivotal roles in the pathogenesis of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML). While inhibitors targeting these pathways effectively suppress the diseases, they fall short in providing enduring remission, largely attributed to cytostatic nature of these drugs. Even combinations of these drugs are ineffective in achieving sustained remission. Enhanced MAPK signaling besides promoting proliferation and survival triggers a pro-apoptotic response...
March 26, 2024: Blood Advances
https://read.qxmd.com/read/38499049/efficacy-and-safety-of-cladribine-in-combination-with-busulfan-and-cyclophosphamide-as-an-intensive-conditioning-regimen-preceding-allogeneic-hematopoietic-stem-cell-transplantation-in-relapsed-or-refractory-acute-myeloid-leukemia
#9
JOURNAL ARTICLE
Fang Xiao, Huanxu Guo, Xueqian Yan, Meiying Qi, Jingyi Zhang
BACKGROUND: Cladribine, an analogue of deoxyadenosine, is used for therapy of hematological malignancies. Cladribine-containing regimen has been recommended as a rescue therapy for relapsed or refractory (R/R) acute myeloid leukemia (AML). Its combination with busulfan plus cyclophosphamide (BuCy), as an intensive conditioning regimen prior to allogeneic hematopoietic stem cell transplantation (allo-HSCT), requires more clinical evidence. This study aimed to explore the efficacy and safety of cladribine plus BuCy administered as an intensive conditioning regimen before allo-HSCT in R/R AML patients...
March 16, 2024: Transplant Immunology
https://read.qxmd.com/read/38481914/the-leukemoid-reaction-in-severe-alcoholic-hepatitis-a-case-report
#10
Siva Reddy, Sachin Agrawal, Sunil Kumar, Sourya Acharya
Alcoholic hepatitis (AH) is a clinicopathologic illness caused by excessive alcohol abuse and is a precursor of cirrhosis. The leukemoid reaction (LR) is characterized by a strikingly raised granulocyte count of 40,000-50,000 cells/mm3 . The LR usually suggests an acute inflammatory reaction. It is usually mistaken for chronic myeloid leukemia. The initial phase of leukocytosis occurs due to the releasing of cells from the bone marrow with more immature cells, causing a left upper shift in the ratio of immature to mature neutrophils and macrophages...
February 2024: Curēus
https://read.qxmd.com/read/38476370/commentary-case-report-chronic-neutrophilic-leukemia-associated-with-monoclonal-gammopathies-a-case-series-and-review-of-genetic-characteristics-and-practical-management
#11
COMMENT
Yifan Deng, Shuai Han, Xiaohui Gao, Yang Liu, Jiapei Gao
No abstract text is available yet for this article.
2024: Frontiers in Oncology
https://read.qxmd.com/read/38461932/invasive-aspergillosis-with-impaired-neutrophil-responses-against-aspergillus-fumigatus-in-patients-treated-with-acalabrutinib-findings-from-three-cases
#12
Marion Blaize, Guillaume Thizy, Alexandre Boissonnas, Anaïs Portalier, Fanny Lanternier, Clémentine de La Porte des Vaux, Felipe Suarez, Marie-Elisabeth Bougnoux, Juliette Guitard, Arnaud Jabet, Nicolas Stocker, Abdelmalek Aoudjhane, Damien Roos-Weil, Arnaud Fekkar
OBJECTIVES: Ibrutinib, a first-generation covalent BTK inhibitor was found to be a risk factor for the occurrence of invasive fungal complications. Acalabrutinib is a second-generation covalent BTKi using to treat B-cell malignancies. Healthy donor neutrophils incubated ex-vivo with acalabrutinib lose ability to control Aspergillus conidia germination. In patients receiving acalabrutinib, the potential effect on neutrophil antifungal activity is unknown. Furthermore, only two cases of invasive aspergillosis have been reported during treatment with acalabrutinib, outside of a few cases in a clinical trial...
March 8, 2024: International Journal of Infectious Diseases: IJID
https://read.qxmd.com/read/38457569/pyoderma-gangrenosum-complicated-with-hematological-malignancies-two-case-reports
#13
JOURNAL ARTICLE
Fen Li, Jie Zhao, Huanan Duan, Haixi Zhang, Lin Zhang, Liangyun Zhao, Yan Wen, Xuezhong Gu
INTRODUCTION: Pyoderma gangrenosum (PG) is a rare noninfectious neutrophilic skin disease. The diagnosis of PG is mainly based on clinical manifestations. Therefore, the clinical features of PG are important for confirming the diagnosis of this disease. Herein, the clinical data of 2 young males with PG complicated with hematological malignancies were reported, and the literature were reviewed. CASE PRESENTATION: The first case was a 22-year-old male who was admitted due to a systemic rash, headache, and fever...
March 8, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38452872/umbilical-cord-blood-transplantation-for-fanconi-anemia-with-a-special-focus-on-late-complications-a-study-on-behalf-of-eurocord-and-saawp-ebmt
#14
JOURNAL ARTICLE
Hanadi Rafii, Fernanda Volt, Marc Bierings, Jean-Hugues Dalle, Mouhab Ayas, Rawad Rihani, Maura Faraci, Giuseppina de Simone, Henrik Sengeloev, Jakob Passweg, Marina Cavazzana, Regis Costello, Johan Maertens, Alessandra Biffi, Jan-Erik Johansson, Juan Montoro, Gabrielle Roth Guepin, Miguel Angel Diaz, Anne Sirvent, Chantal Kenzey, Monica M Rivera Franco, Barbara Cappelli, Graziana Maria Scigliuolo, Vanderson Rocha, Annalisa Ruggeri, Antonio Risitano, Regis Peffault De Latour, Eliane Gluckman
BACKGROUND: Hematopoietic cell transplant (HCT) remains the only available curative treatment for Fanconi Anemia (FA), with particularly favorable outcomes reported after matched sibling donor (MSD) transplant. OBJECTIVES: To describe outcomes, with a special focus on late complications, in FA patients who underwent umbilical cord blood transplantation (UCBT). STUDY DESIGN: Retrospective analysis of allogeneic UCBT for FA performed between 1988 and 2021 in European Society for Blood and Marrow Transplantation (EBMT) affiliated centers...
March 5, 2024: Transplantation and cellular therapy
https://read.qxmd.com/read/38412763/low-shear-stress-exacerbates-atherosclerosis-by-inducing-the-generation-of-neutrophil-extracellular-traps-via-piezo1-mediated-mechanosensation
#15
JOURNAL ARTICLE
Ying Zhu, Tian Wang, Yan Yang, Zining Wang, Xiaohui Chen, Liu Wang, Ruyan Niu, Zixin Sun, Chong Zhang, Yang Luo, Yijie Hu, Wei Gu
BACKGROUND AND AIMS: Atherosclerosis is a chronic lipid-driven inflammatory disease largely influenced by hemodynamics. Neutrophil extracellular trap (NET)-mediated inflammation plays an important role in atherosclerosis. However, little is known about the relationship between low shear stress (LSS) and NET generation, as well as the underlying mechanism. METHODS: We induced LSS by partial ligation of the left carotid artery in high-fat diet-fed male ApoE-/- mice...
February 10, 2024: Atherosclerosis
https://read.qxmd.com/read/38396385/neutrophilic-leukemoid-reaction-or-chronic-neutrophilic-leukemia-not-always-so-simple
#16
Yorick Sandberg, Leo M Budel, Barbara J Bain
No abstract text is available yet for this article.
February 23, 2024: American Journal of Hematology
https://read.qxmd.com/read/38284270/validation-of-a-novel-algorithm-with-a-high-specificity-in-ruling-out-mds
#17
JOURNAL ARTICLE
Felicitas Schulz, Kathrin Nachtkamp, Howard S Oster, Moshe Mittelman, Norbert Gattermann, Sarah Schweier, Carmen Barthuber, Ulrich Germing
INTRODUCTION: A previously published web-based App using Gradient-boosted models (GBMs) of eight laboratory parameters was established by Oster et al. to facilitate diagnosis or exclusion of myelodysplastic syndromes (MDS) in patients. METHODS: To validate their algorithm, we compared 175 anemic patients with MDS diagnosis from our German MDS Registry with 1378 non-MDS anemic patients who consulted various specialties in the Düsseldorf university hospital. RESULTS: Based on hemoglobin level, leukocyte and platelet count, mean corpuscular volume, absolute neutrophil count, absolute monocyte count, glucose and creatinine, plus the patients' gender and age, we could not reproduce a high negative predictive value (NPV), but confirmed a useful specificity of 90...
January 29, 2024: International Journal of Laboratory Hematology
https://read.qxmd.com/read/38269572/essential-thrombocythemia-2024-update-on-diagnosis-risk-stratification-and-management
#18
JOURNAL ARTICLE
Ayalew Tefferi, Alessandro Maria Vannucchi, Tiziano Barbui
OVERVIEW: Essential thrombocythemia is a Janus kinase 2 (JAK2) mutation-prevalent myeloproliferative neoplasm characterized by clonal thrombocytosis; clinical course is often indolent but might be interrupted by thrombotic or hemorrhagic complications, microcirculatory symptoms (e.g., headaches, lightheadedness, and acral paresthesias), and, less frequently, by disease transformation into myelofibrosis (MF) or acute myeloid leukemia. DIAGNOSIS: In addition to thrombocytosis (platelets ≥450 × 109 /L), formal diagnosis requires the exclusion of other myeloid neoplasms, including prefibrotic MF, polycythemia vera, chronic myeloid leukemia, and myelodysplastic syndromes with ring sideroblasts and thrombocytosis...
January 25, 2024: American Journal of Hematology
https://read.qxmd.com/read/38256031/clofarabine-preconditioning-followed-by-allogeneic-transplant-using-tbi-and-post-transplant-cyclophosphamide-for-relapsed-refractory-leukemia
#19
Seema Naik, Kevin Rakszawski, Hong Zheng, David Claxton, Kentaro Minagawa, Shin Mineishi
Acute myeloid leukemia patients with induction failure or relapsed refractory disease have minimal chance of achieving remission with subsequent treatments. Several trials have shown the feasibility of clofarabine-based conditioning in allogeneic stem cell transplants (allo-HSCT) for non-remission AML patients. Pre-transplant conditioning with clofarabine followed by reduced-intensity allo-HSCT has also demonstrated a potential benefit in those patients with human leukocyte antigen (HLA)-identical donors, but it is not commonly used in haploidentical and mismatched transplants...
January 12, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38254802/myeloproliferative-neoplasms-diseases-mediated-by-chronic-activation-of-signal-transducer-and-activator-of-transcription-stat-proteins
#20
REVIEW
Clifford Liongue, Alister C Ward
Myeloproliferative neoplasms (MPNs) are hematopoietic diseases characterized by the clonal expansion of single or multiple lineages of differentiated myeloid cells that accumulate in the blood and bone marrow. MPNs are grouped into distinct categories based on key clinical presentations and distinctive mutational hallmarks. These include chronic myeloid leukemia (CML), which is strongly associated with the signature BCR::ABL1 gene translocation, polycythemia vera (PV), essential thrombocythemia (ET), and primary (idiopathic) myelofibrosis (PMF), typically accompanied by molecular alterations in the JAK2 , MPL , or CALR genes...
January 11, 2024: Cancers
keyword
keyword
38998
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.